Stefan Willmann

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 12

Top Topics

Polycyclic Aromatic Hydrocarbons

Electronic Health Record

Pulmonary Arterial Hypertension

Ultrasound Guided

Top Venues

Pediatric pulmonology

Clinical and translational science

CPT: pharmacometrics & systems pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Tianxing Liu, Kensei Hashizume, Eva Krieg, Huijun Chen, Yuki Mukaida, Kirstin Thelen, Frauke Friedrichs, Stefan Willmann, Stephan Schwers, Alexander Solms, Rosie Yu
Pharmacokinetics, pharmacodynamics, and safety of fesomersen, a novel antisense inhibitor of factor XI, in healthy Chinese, Japanese, and Caucasian volunteers. Clinical and translational science 17 (4) (2024)
Stefan Willmann, Adam Lloyd, Rupert Austin, Shiju Joseph, Alexander Solms, Yang Zhang, Annika R P Schneider, Sebastian Frechen, Marcus-Hillert Schultze-Mosgau
Population pharmacokinetic-pharmacodynamic model of elinzanetant based on integrated clinical phase I and II data. CPT: pharmacometrics & systems pharmacology (2024)
Tianxing Liu, Kensei Hashizume, Eva Krieg, Huijun Chen, Yuki Mukaida, Kirstin Thelen, Frauke Friedrichs, Stefan Willmann, Stephan Schwers, Alexander Solms, Rosie Yu
Pharmacokinetics, pharmacodynamics, and safety of fesomersen, a novel antisense inhibitor of factor XI, in healthy Chinese, Japanese, and Caucasian volunteers. Clinical and translational science 17 (4) (2024)
Tianxing Liu, Kensei Hashizume, Eva Krieg, Huijun Chen, Yuki Mukaida, Kirstin Thelen, Frauke Friedrichs, Stefan Willmann, Stephan Schwers, Alexander Solms, Rosie Yu
Pharmacokinetics, pharmacodynamics, and safety of fesomersen, a novel antisense inhibitor of factor XI, in healthy Chinese, Japanese, and Caucasian volunteers. Clinical and translational science 17 (4) (2024)
Tianxing Liu, Kensei Hashizume, Eva Krieg, Huijun Chen, Yuki Mukaida, Kirstin Thelen, Frauke Friedrichs, Stefan Willmann, Stephan Schwers, Alexander Solms, Rosie Yu
Pharmacokinetics, pharmacodynamics, and safety of fesomersen, a novel antisense inhibitor of factor XI, in healthy Chinese, Japanese, and Caucasian volunteers. Clinical and translational science 17 (4) (2024)
Stefan Willmann, Ibrahim Ince, Maurice J Ahsman, Katrin Coboeken, Yang Zhang, Kirstin Thelen, Dagmar Kubitza, Peter Zannikos, Wangda Zhou, Liza Miriam Pina, Teun M Post, Joerg Lippert
Model-informed bridging of rivaroxaban doses for thromboprophylaxis in pediatric patients aged 9 years and older with congenital heart disease. CPT: pharmacometrics & systems pharmacology 11 (8) (2022)
Stefan Willmann, Andrea Kerstin Keller, Michaela Meyer, Dorina van der Mey, Gabriela Wirsching, Yang Zhang, Henk-Jan Drenth, Anne Keunecke, Esmée Vendel, Soundos Saleh
Population pharmacokinetics of riociguat in a pediatric population (aged ≥6 years) with pulmonary arterial hypertension. Pediatric pulmonology (2022)
Stefan Willmann, Andrea Kerstin Keller, Michaela Meyer, Dorina van der Mey, Gabriela Wirsching, Yang Zhang, Henk-Jan Drenth, Anne Keunecke, Esmée Vendel, Soundos Saleh
Population pharmacokinetics of riociguat in a pediatric population (aged ≥ 6 years) with pulmonary arterial hypertension. Pediatric pulmonology 58 (3) (2022)
Stefan Willmann, Andrea Kerstin Keller, Michaela Meyer, Dorina van der Mey, Gabriela Wirsching, Yang Zhang, Henk-Jan Drenth, Anne Keunecke, Esmée Vendel, Soundos Saleh
Population pharmacokinetics of riociguat in a pediatric population (aged ≥ 6 years) with pulmonary arterial hypertension. Pediatric pulmonology 58 (3) (2022)
Stefan Willmann, Andrea Kerstin Keller, Michaela Meyer, Dorina van der Mey, Gabriela Wirsching, Yang Zhang, Henk-Jan Drenth, Anne Keunecke, Esmée Vendel, Soundos Saleh
Population pharmacokinetics of riociguat in a pediatric population (aged ≥ 6 years) with pulmonary arterial hypertension. Pediatric pulmonology 58 (3) (2022)
Stefan Willmann, Andrea Kerstin Keller, Michaela Meyer, Dorina van der Mey, Gabriela Wirsching, Yang Zhang, Henk-Jan Drenth, Anne Keunecke, Esmée Vendel, Soundos Saleh
Population pharmacokinetics of riociguat in a pediatric population (aged ≥ 6 years) with pulmonary arterial hypertension. Pediatric pulmonology (2022)
Stefan Willmann, Eleonora Marostica, Nelleke Snelder, Alexander Solms, Markus Jensen, Maximilian Lobmeyer, Anthonie W A Lensing, Claudette Bethune, Erin Morgan, Rosie Z Yu, Yanfeng Wang, Shiangtung W Jung, Richard Geary, Sanjay Bhanot
PK/PD modeling of FXI antisense oligonucleotides to bridge the dose-FXI activity relation from healthy volunteers to end-stage renal disease patients. CPT: pharmacometrics & systems pharmacology 10 (8) (2021)